Preparation for surgical treatment of patients with severe forms of pelvic organ prolapse complicated by trophic disorders


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. Improvement of the results of preop erative preparation of women with III-IV stage genital prolapse and trophic disorders of the vaginal and cervical mucosa. Methods. A prospective, observational, non-interventional, non-comparative clinical included 51 patients with III-IV grade pelvic organ prolapse (POP) with the presence of decubital ulcers of the vaginal and cervix mucosa. The POP degree was determined according to the POP-Q classification. For complex treatment, perforated cubic Dr Arabin pessaries with individual size selection were used. Decubital ulcers were treated by irrigation with cavitated solutions, in some cases using argon plasma coagulation (once), a gel with chlorhexidine/allantoin and an estriol-containing cream. Results. The participants’ age was 34-87years, mean age 66.9±12.7 years. Complete epithelization of ulcerative defects was achieved in all cases (100%), the average healing time for ulcerous defects was 11.3±2.4 days. The frequency of replacing the size of the pessary was 23.5% within 1 month. The incidence of side effects was 1.1%. After ulcer healing, 47.1% of patients underwent surgery, the rest chose a pessary for further use. Conclusion. Comprehensive treatment using irrigation with cavitated solutions of aniseptics, pessaries, estriol and agents with an epithelizing effect is an integral part of the preoperative preparation of patients with severe prolapse and decubital ulcers, which allows achieving a fairly quick positive effect in 100% of cases and makes it possible to carry out surgical treatment in conditions of normal tissue trophism.

Full Text

Restricted Access

About the authors

Evgeny Yu. Glukhov

Ural State Medical University; Center for Operative Gynecology “Women's Clinic"

Email: 9222241411@mail.ru
Dr. Sci. (Med.), Professor, Department of Obstetrics and Gynecology

G. B Dikke

Academy of Medical Education n.a. F.I. Inozemtsev

E. I Neff

Center for Operative Gynecology “Women's Clinic"

M. O Roshchina

City Clinical Hospital № 40, Yekaterinburg

References

  1. Masenga G.G., Shayo B.C., Rasch V. Prevalence and risk factors for pelvic organ prolapse in Kilimanjaro, Tanzania: A population based study in Tanzanian rural community. PLoS One. 2018; 13(4):e0195910. doi: 10.1371/journal.pone.0195910.
  2. Sze E.H., Hobbs G. Relation between vaginal birth and pelvic organ prolapse. Acta Obstet. Gynecol. Scand. 2009;88(2):200-3.
  3. Gumanga S.K., Munkaila A., Malechi H. Social demographic characteristics of women with pelvic organ prolapse at the Tamale Teaching Hospital, Ghana. Ghana Med J. 2014;48(4):208-13. doi: 10.4314/gmj.v48i4.7.
  4. Narins H., Danforth T.L. Management of pelvic organ prolapse in the elderly - is there a role for robotic-assisted sacrocolpopexy? Robot Surg. 2016;3:65-73. doi: 10.2147/RSRR.S81584.
  5. Deshpande H.G., Madkar C.S., Kiwalkar S.R. Relationship of Decubitus Ulcer on Cervix in Pelvic Organ Prolapse with POP-Q Staging. J. Obstet Gynaecol India. 2019;69(3):266-71. doi: 10.1007/s13224-018-1127-3.
  6. Кавитированные растворы в репродуктивной медицине. Под ред. В.Е. Радзинского, Е.Ю. Глухова. М., 2017. 341 с.
  7. Радиоволна и аргоновая плазма в практике акушера-гинеколога. Под ред. В.Е. Радзинского и литературных источников, написание статьи и ее редактирование после рецензирования. Е.Ю. Глухова. М., 2016. 216 с.
  8. Дикке Г.Б., Аполихина И.А., Кочев Д.М., Щербатых Е.Ю. Распространенность дисфункции тазового дна среди акушеров-гинекологов и факторы, влияющие на выбор терапевтических подходов. Акушерство и гинекология. 2017;10:111-19
  9. Артымук Н.В., Хапачева С.Ю. Распространенность симптомов дисфункции тазового дна у женщин репродуктивного возраста. Акушерство и гинекология. 2018;9:98-104
  10. Coolen A.W.M., Troost S., Mol B.W.J., et al. Primary treatment of pelvic organ prolapse: pessary use versus prolapse surgery. Int Urogynecol J. 2018;29(1):99-107. doi: 10.1007/s00192-017-3372-x
  11. Jundt K., Peschers U., Kentenich H. The investigation and treatment of female pelvic floor dysfunction. Dtsch Arztebl Int. 2015;112(33-34):564-74. doi: 10.3238/arztebl.2015.0564.
  12. Lamers B.H., Broekman B.M., Milani A.L. Pessary treatment for pelvic organ prolapse and health-related quality of life: a review. Int Urogynecol J. 2011;22(6):637-44. doi: 10.1007/s00192-011-1390-7.
  13. RobertM., Schulz J.A., HarveyM.A.; Urogynaecology Committee. Technical update on pessary use. J Obstet Gynaecol Can. 2013;35(7):664-74. doi: 10.1016/S1701-2163(15)30888-4.
  14. Santen R.J., Allred D.C., Ardoin S.P, et al. Endocrine Society. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2010;95(7 Suppl. 1):s1-66. doi: 10.1210/jc.2009-250.
  15. Shen J., Song N., Williams C.J., et al. Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis. Sci Rep. 2016;6:24380. doi: 10.1038/srep24380.
  16. Lethaby A., Ayeleke R.O., Roberts H., et al. Local oestrogen for vaginal atrophy in postmenopausal women (Review). Cochrane Database Syst Rev. 2016;8:CD001500. doi: 10.1002/14651858. CD001500.pub3.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies